Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Journal of Medical Virology
|
October 27, 2017
Performance evaluation of Cepheid Xpert Norovirus kit with a user-modified protocol
Rachel Shi-Lei Wong, Fion Yeo, Wai Theng Chia, et al.
Clinical and Translational Medicine
|
September 8, 2020
Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response
Jingjing Li, Qing Wei, Xiaoying Wu, et al.
Science Advances
|
January 9, 2026
Impaired nitrogenous waste clearance promotes hepatocellular carcinoma
Xinlu Han, Jianliang Shen, Junrong Yan, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
January 22, 2021
The Ubiquitin E3 Ligase TRIM21 Promotes Hepatocarcinogenesis by Suppressing the p62-Keap1-Nrf2 Antioxidant Pathway
Fang Wang, Ye Zhang, Jianliang Shen, et al.
BMC Medicine
|
July 22, 2025
Multi-omics analysis uncovers predictive biomarkers for the efficacy and outcomes of chemoimmunotherapy in advanced unresectable biliary tract cancers
Jiaojiao Ni, Chaoqun Li, Xiaoqing Xu, et al.
Biorxiv : the Preprint Server for Biology
|
February 9, 2026
OSTM1 is a ubiquitin E3 ligase that suppresses B-cell malignancy by activating the cAMP/PKA/CREB pathway
Muhammad Usama Tariq, Namratha Sheshadri, Jianliang Shen, et al.
Oncogene
|
December 14, 2019
Correction: Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation
Ying Jin, Hua Bao, Xiuning Le, et al.
Oncogene
|
November 23, 2019
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation
Ying Jin, Hua Bao, Xiuning Le, et al.
Nature Communications
|
March 28, 2020
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma
Li Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Journal of Medical Virology
|
October 27, 2017
Performance evaluation of Cepheid Xpert Norovirus kit with a user-modified protocol
Rachel Shi-Lei Wong, Fion Yeo, Wai Theng Chia, et al.
Clinical and Translational Medicine
|
September 8, 2020
Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response
Jingjing Li, Qing Wei, Xiaoying Wu, et al.
Science Advances
|
January 9, 2026
Impaired nitrogenous waste clearance promotes hepatocellular carcinoma
Xinlu Han, Jianliang Shen, Junrong Yan, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
January 22, 2021
The Ubiquitin E3 Ligase TRIM21 Promotes Hepatocarcinogenesis by Suppressing the p62-Keap1-Nrf2 Antioxidant Pathway
Fang Wang, Ye Zhang, Jianliang Shen, et al.
BMC Medicine
|
July 22, 2025
Multi-omics analysis uncovers predictive biomarkers for the efficacy and outcomes of chemoimmunotherapy in advanced unresectable biliary tract cancers
Jiaojiao Ni, Chaoqun Li, Xiaoqing Xu, et al.
Biorxiv : the Preprint Server for Biology
|
February 9, 2026
OSTM1 is a ubiquitin E3 ligase that suppresses B-cell malignancy by activating the cAMP/PKA/CREB pathway
Muhammad Usama Tariq, Namratha Sheshadri, Jianliang Shen, et al.
Oncogene
|
December 14, 2019
Correction: Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation
Ying Jin, Hua Bao, Xiuning Le, et al.
Oncogene
|
November 23, 2019
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation
Ying Jin, Hua Bao, Xiuning Le, et al.
Nature Communications
|
March 28, 2020
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma
Li Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, et al.
Page
of 7